The most IBM-specific markers of type 1 inflammation were the ligand-receptor pair CCL5-CCR5 (first and sixth most differentially overexpressed genes in IBM), while IBM patients also exhibited markedly higher median expression of the TH1/TC1 marker CXCR3 and IFNG than other groups. Here, CCL5 is linked to inclusion body myositis.